Skip to main content
Kalpesh Patel, DO, Research, Apex, NC

Kalpesh P. Patel DO


Senior Medical Director- Abbvie

Join to view full profile
  • 120 Healthplex WayApex, NC 27523

Dr. Patel is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Kalpesh Patel, DO, is located in Apex, NC, and specializes in Cancer drug development focusing on patient safety. Patel completed a pediatrics residency from 2002 to 2005 at Atlantic Health and graduated from NYIT College of Osteopathic Medicine in 2002. Patel has authored publications focused on oncology research, with studies addressing the safety and efficacy of treatments for advanced glioblastoma, chronic lymphocytic leukemia/small lymphocytic lymphoma, mantle cell lymphoma, and the cardiac safety of afatinib.

Education & Training

  • Atlantic Health
    Atlantic HealthResidency, Pediatrics, 2002 - 2005
  • NYIT College Of Osteopathic Medicine
    NYIT College Of Osteopathic MedicineClass of 2002

Certifications & Licensure

  • NJ State Medical License
    NJ State License 2005 - 2027

Publications & Presentations

Journal Articles

  • Phase I study of anti-epidermal growth factor receptor antibody-drug conjugate serclutamab talirine: Safety, pharmacokinetics, and antitumor activity in advanced gliob...  
    Carneiro BA,…..Patel K, et al., NeuroOncology Advances
  • Safety Analysis of Four Randomized Controlled Studies of Ibrutinib in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Mantle Cell Lymphoma  
    Susan O'Brien1,∗,correspondenceEmail the author Susan O'Brien, Peter Hillmen2, Steven Coutre3, Paul M. Barr4, Graeme Fraser5, Alessandra Tedeschi6, Jan A. Burger7, Mar..., Clinical Lymphoma, Myeloma, and Leukemia
  • Cardiac Safety of Afatinib: a review of data from clinical trials  
    Ewer M, Patel K, Cardio Oncology, 11/26/2015

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: